- Vancouver Tech Journal
- Posts
- Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Bulletin: Despite domestic snubbing, AbCellera made nearly $200 million off of its COVID-19 treatment
Plus, it generated a net profit of $119 million USD, up from a net loss of $2 million on $11.6 million in revenue.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/6d8a0e99-ae4e-48a6-9a01-d7b61c64c7a5/186168f4-a48f-471c-baa8-d20ae7420f45_1480x1008.jpg?t=1690482749)
Premium Content
Become a paying subscriber of Vancouver Tech Journal to get access to this page and other subscriber-only content.
What you get when you upgrade:
Already a subscriber?Sign In.Upgrade to view premium content.- 🔑 Exclusive content: In-depth stories that you won't find anywhere else
- 🎟️ First access to events we put on
- 🔒 The Morning Report, an email digest of need-to-know stories and deals
- 🗓️ Discounted and invitation-only events